ライフサイエンスコーパス: bioterrorism

1 for public safety amid the growing threat of bioterrorism.

2 th the potential for subversion as agents of bioterrorism.

3 threat to humans and is a potential agent of bioterrorism.

4 t is presently feared as a possible agent of bioterrorism.

5 spread of infectious diseases and potential bioterrorism.

6 e agent of anthrax and a potential weapon of bioterrorism.

7 orly immunogenic vaccines, and the threat of bioterrorism.

8 fever and is considered a potential agent of bioterrorism.

9 l in humans and could be used as an agent of bioterrorism.

10 infectiousness make it a potential agent of bioterrorism.

11 because of its potential use as an agent of bioterrorism.

12 s of an epidemic model, focusing on smallpox bioterrorism.

13 ay not be applicable to some threats such as bioterrorism.

14 ty, has increased exponentially in an age of bioterrorism.

15 reating infections caused by these agents of bioterrorism.

16 odel may be needed to address the threats of bioterrorism.

17 f the AIDS pandemic and the threat of global bioterrorism.

18 a) poses a significant threat as an agent of bioterrorism.

19 disease, and they pose a threat as agents of bioterrorism.

20 ion in indoor environments and the threat of bioterrorism.

21 cal diagnosis, and the current fight against bioterrorism.

22 ns that it might be exploited as a weapon of bioterrorism.

23 otential for international spread and use in bioterrorism.

24 ermeasures to combat this potential agent of bioterrorism.

25 adequate plans for dealing with agricultural bioterrorism.

26 icity, superantigens are potential agents of bioterrorism.

27 ghly infectious agents that may be agents of bioterrorism.

28 of protecting against such future threats of bioterrorism.

29 re one of the highest-risk threat agents for bioterrorism.

30 also well recognized as a potential agent of bioterrorism.

31 event the potentially devastating effects of bioterrorism.

32 e deadliest agents of biological warfare and bioterrorism.

33 nited States experienced a deliberate act of bioterrorism.

34 ularensis bacteria, a Tier 1 Select Agent of bioterrorism.

35 sepsis and is a major concern as a weapon of bioterrorism.

36 e case of malignancy, pandemic infection, or bioterrorism.

37 category (category A) of potential agents of bioterrorism.

38 there is concern that MPXV could be used for bioterrorism.

39 nt of anthrax disease, is a proven weapon of bioterrorism.

40 lity, ricin is considered a likely agent for bioterrorism.

41 A select agent and thus a potential agent of bioterrorism.

42 enic and classified as a category A agent of bioterrorism.

43 attention because of its potential use as a bioterrorism agent and inadvertent introduction into Nor

44 tructure of PNGM from the human pathogen and bioterrorism agent Bacillus anthracis.

45 Bacillus anthracis is a bioterrorism agent classified by the Centers for Disease

46 ons in ultrasensitive molecular diagnostics, bioterrorism agent detection, and real-time imaging and

47 or Disease Control and Prevention Category A bioterrorism agent Francisella tularensis and prototype

48 Francisella tularensis is a potential bioterrorism agent that is highly infectious at very low

49 ccines and antibiotics against the potential bioterrorism agent Yersinia pestis.

50 of the intracellular pathogen and potential bioterrorism agent, Brucella suis, was determined.

51 ly virulent zoonotic pathogen and category B bioterrorism agent, was sequenced by the random shotgun

52 to wide availability and potential use as a bioterrorism agent, with particular concern for food sup

53 t smallpox because of its potential use as a bioterrorism agent.

54 has recently been classified as a category A bioterrorism agent.

55 causative agent of anthrax, is a well known bioterrorism agent.

56 so recently received attention as a possible bioterrorism agent.

57 ed as a Tier 1 select agent and a category A bioterrorism agent.

58 e causative agent of anthrax, is a potential bioterrorism agent.

59 tein synthesis and is considered a potential bioterrorism agent.

60 ar bacterium Coxiella burnetii, a category B bioterrorism agent.

61 rom the potential use of smallpox virus as a bioterrorism agent.

62 en to assess water quality and as a possible bioterrorism agent.

63 s and is currently of concern as a potential bioterrorism agent.

64 ity, genetic homogeneity, and potential as a bioterrorism agent.

65 n, ricin has been classified as a category B bioterrorism agent.

66 ausative agent of tularemia, is a category A bioterrorism agent.

67 se concern because of its potential use as a bioterrorism agent.

68 ant cause of food poisoning and is a class B bioterrorism agent.

69 is an important human pathogen and potential bioterrorism agent.

70 de an attractive technology platform against bioterrorism agents due to their safety record in humans

71 Heightened fear of bioterrorism agents has caused health officials to re-ex

72 Furthermore, detection of bioterrorism agents in water, food and environmental sam

73 ct pathogenic bacteria, especially potential bioterrorism agents like Yersinia pestis and Bacillus an

74 er, multidrug-resistant strains of bacterial bioterrorism agents occur naturally or have been bio-eng

75 For example, the bioterrorism agents of greatest concern cause initial sy

76 umber of protein toxins, including potential bioterrorism agents such as ricin and botulinum neurotox

77 l pyrogenic exotoxins] and anthrax toxin are bioterrorism agents that cause diseases by immunostimula

78 has been developed for specific detection of bioterrorism agents, as exemplified by ricin, cholera to

79 the most potent toxins known, are potential bioterrorism agents.

80 consideration in designing therapeutics for bioterrorism agents.

81 the treatment of disease caused by potential bioterrorism agents.

82 fever with high mortality and are potential bioterrorism agents.

83 mallei and Burkholderia mallei are potential bioterrorism agents.

84 accines as well as their potential misuse as bioterrorism agents.

85 ns in humans and are high-priority potential bioterrorism agents.

86 o emerging infectious diseases and potential bioterrorism agents.

87 e common infectious processes from agents of bioterrorism also could improve management strategies.

88 Bioterrorism and abortion were also important issues for

89 continues to generate concern as an agent of bioterrorism and as a natural cause of sporadic disease

90 ures make Ebola virus a potential weapon for bioterrorism and biological warfare.

91 so more recent issues such as food security, bioterrorism and climate change.

92 Concerns over bioterrorism and emerging diseases have led to the wides

93 ations of surveillance systems for detecting bioterrorism and emerging infections are insufficient to

94 e in vaccinating against potential agents of bioterrorism and emerging infections because of their pr

95 gnostics with major impacts in areas such as bioterrorism and food safety.

96 Concerns about bioterrorism and influenza have focused attention on ide

97 Thus, rapid methods to distinguish between bioterrorism and naturally occurring plague infections a

98 The unpredictable nature of bioterrorism and the absence of real-time detection syst

99 Given the threat of bioterrorism and the increasing availability of electron

100 use of the potential for use of the toxin in bioterrorism and the increasingly widespread application

101 alth threats both through the possibility of bioterrorism and the intentional release of smallpox and

102 Tube extracts from several agents of bioterrorism and their near neighbors were analyzed in a

103 From a bioterrorism and warfare perspective, these agents are l

104 s and are considered as potential agents for bioterrorism and warfare.

105 number of mechanisms, which include disease, bioterrorism, and destruction of both plant and animal f

106 cause major public concern for food safety, bioterrorism, and nosocomial infections.

107 , whether naturally occurring or a result of bioterrorism, and thus can be an integral component of a

108 ct against radiation toxicities from acts of bioterrorism, as well as cancer treatment.

109 de a model for the study of both natural and bioterrorism associated disease.

110 Prevention or therapy for bioterrorism-associated anthrax infections requires rapi

111 of intense study as a result of its use in a bioterrorism attack in the United States in September an

112 ients with inhalational anthrax related to a bioterrorism attack in the United States.

113 In 2001, a bioterrorism attack involving Bacillus anthracis spore-l

114 arth and represent a serious problem for (i) bioterrorism attack, (ii) horizontal transmission of mic

115 y data to detect a large-scale but localized bioterrorism attack.

116 tment and reduce mortality in the event of a bioterrorism attack.

117 ion and more rapid therapy in the event of a bioterrorism attack.

118 The agents most likely to be used in bioterrorism attacks are reviewed, along with the clinic

119 an essential role in the pathogenesis of the bioterrorism bacterium Bacillus anthracis.

120 thods to the analysis of evidence related to bioterrorism, biocrimes, hoaxes, or the accidental relea

121 (from 1966 to 2004) for articles relating to bioterrorism, biological agents, biological warfare, hos

122 is, biological weapon, biological terrorism, bioterrorism, biological warfare, and biowarfare.

123 its classification as a category A agent of bioterrorism, but little is known about the molecular me

124 ularemia and a category A potential agent of bioterrorism, but the pathogenic mechanisms of F. tulare

125 y can become much better prepared to counter bioterrorism by developing a list of likely anti-crop th

126 ion in humans and animals and has been a top bioterrorism concern since the 2001 anthrax attacks in t

127 Bacillus anthracis remains a serious bioterrorism concern, and the currently licensed vaccine

128 f botulinum neurotoxin (BoNT) is a potential bioterrorism concern.

129 iruses are under intense research because of bioterrorism concerns, zoonotic infections, and the side

130 importance of dermatologist preparedness for bioterrorism, dermatologist knowledge regarding smallpox

131 Surveillance for bioterrorism detection, in particular, raises unique iss

132 surveillance systems, 20 systems collecting bioterrorism detector data, 13 systems collecting influe

133 We simulated outbreaks for these bioterrorism diseases and evaluated the performance of o

134 rriers to surge capacity in the setting of a bioterrorism event and to identify solutions to these pr

135 During the bioterrorism event of 2001, we applied two novel immunoh

136 and may impact public health management of a bioterrorism event.

137 role of pathology in investigating potential bioterrorism events and in guiding epidemiological studi

138 national capacities to detect and respond to bioterrorism events and naturally occurring outbreaks of

139 plague and the forensic analysis of possible bioterrorism events.

140 d it has been invoked in federally sponsored bioterrorism exercises.

141 cumented inhalational anthrax resulting from bioterrorism exposure are presented.

142 rensic science, embryonic disease diagnosis, bioterrorism genome detection, "immortalization" of clin

143 e agent of anthrax and a potential weapon of bioterrorism, grows rapidly in mammalian hosts, which su

144 As the potential for bioterrorism has appeared to increase, the need for simp

145 The possibility of bioterrorism has been met by significant financial outla

146 20 years ago, its potential release through bioterrorism has generated renewed interest in vaccinati

147 naturally occurring smallpox, the threat of bioterrorism has led to renewed vaccination programs.

148 lnesses and syndromes potentially related to bioterrorism have proliferated.

149 Threats of bioterrorism have renewed efforts to better understand p

150 surge capacities to deal with a significant bioterrorism incident.

151 e of renewed interest in potential agents of bioterrorism, including Y. pestis.

152 ng clinicians and laboratorians to potential bioterrorism-initiated outbreaks as well as look-alike d

153 in part to recently heightened concern over bioterrorism, interest in the mechanism of action of bot

154 Combating bioterrorism is a challenge to all of us.

155 n response to a select agent event or act of bioterrorism is reviewed.

156 ther through natural means or as a result of bioterrorism, is of significant concern.

157 trategies would provide a better response to bioterrorism, mass vaccination, or vaccination of social

158 o get ready, and in the process be ready for bioterrorism, natural disasters, and epidemics of other

159 h the powers they need to detect and contain bioterrorism or a naturally occurring disease outbreak.

160 is may be deliberately released in an act of bioterrorism or war.

161 bioaerosol is of the greatest concern from a bioterrorism or warfare perspective, potentially capable

162 (SEB) may occur accidentally, as a result of bioterrorism, or during colonization or infection of the

163 gnized as potential agents of biowarfare and bioterrorism owing to their morbidity and mortality in h

164 s, and their potential use as instruments of bioterrorism, pose a significant threat to the developed

165 Bioterrorism poses a daunting challenge to global securi

166 Bioterrorism poses a major threat to public health, as t

167 ct Terrorism" (USA PATRIOT) Act and the 2002 Bioterrorism Preparedness Act on US select agent researc

168 em data were designed, at least in part, for bioterrorism preparedness applications.

169 ts) demanded in the medical, veterinary, and bioterrorism prevention arenas.

170 spans from human and veterinary medicine to bioterrorism prevention.

171 Despite having a laboratory bioterrorism procedure in place and adhering to establis

172 Bioterrorism provides a powerful metaphor for elite fear

173 to immune plasma and an effective dual use (bioterrorism/public health) therapeutic.

174 cult to differentiate from illness caused by bioterrorism, rapidly spreading infection, or toxic subs

175 d poor life adjustment 1 year after onset of bioterrorism-related anthrax disease.

176 Bioterrorism-related anthrax exposures occurred at the U

177 d 47 historical cases (including 11 cases of bioterrorism-related anthrax) with 376 controls with com

178 about potential long-term health effects of bioterrorism-related Bacillus anthracis infection.

179 cell responses were studied in patients with bioterrorism-related cutaneous or inhalation anthrax and

180 ical and IHC studies of patients who died of bioterrorism-related inhalational anthrax confirmed the

181 We describe the 11th case of bioterrorism-related inhalational anthrax reported in th

182 During the recent bioterrorism-related outbreaks, inhalational anthrax had

183 in public health and related fields such as bioterrorism response and preparedness.

184 ed in 1951 to be a defense against potential bioterrorism, serve the immediate needs for field invest

185 environmental relatives of select agents of bioterrorism significance.

186 rns about the use of smallpox as a weapon of bioterrorism since the world events in recent years.

187 se research expands to counter the threat of bioterrorism, so does suspicion and the need for guidanc

188 deployed for both event-based and continuous bioterrorism surveillance.

189 to-person transmission, and potential use in bioterrorism, the development of a vaccine against ebola

190 ry syndrome (SARS), the continuing threat of bioterrorism, the proliferation of West Nile virus, and

191 in and other fast-acting toxins as agents of bioterrorism, there is an urgent need for the developmen

192 It is also listed as a category B bioterrorism threat agent by the U.S. Centers for Diseas

193 Bacillus anthracis, a bioterrorism threat as well as an agricultural concern,

194 ing clinical specimens, field samples during bioterrorism threat assessment, and samples from outbrea

195 ation of Yersinia pestis, represents a major bioterrorism threat for which no vaccine is available.

196 its ease of production have made it a major bioterrorism threat worldwide.

197 Smallpox constitutes a major bioterrorism threat, which underscores the need to devel

198 The toxin is also a bioterrorism threat, yet no pharmacological antagonist t

199 l disease that has re-emerged as a potential bioterrorism threat.

200 orrhagic fever in humans and pose a credible bioterrorism threat.

201 gic fever in humans and also pose a credible bioterrorism threat.

202 n, and gastroenteritis and poses a potential bioterrorism threat.

203 rograms for this important public health and bioterrorism threat.

204 , DNA vaccines against emerging pathogens or bioterrorism threats can be quickly constructed based so

205 In response to bioterrorism threats, anthrax vaccine has been used by t

206 d activity, combined with today's climate of bioterrorism threats, has heightened the need for high-t

207 inue to be delivered in response to possible bioterrorism threats.

208 lness after inhalation make some rickettsiae bioterrorism threats.

209 Bioterrorism using anthrax claimed five lives in the Uni

210 Only a few years ago bioterrorism was considered a remote concern but few tod

211 Until 1997, the subject of bioterrorism was not discussed within the medical commun

212 With the threat of smallpox virus as a bioterrorism weapon, questions have been asked about the

213 lla tularensis (Ft) is a potential weapon of bioterrorism when aerosolized.

214 Possible bioterrorism with smallpox has led to the resumption of

215 The concern about bioterrorism with smallpox has raised the possibility of

216 In response to possible bioterrorism with smallpox, the UK government vaccinated